Rj. Robinson et al., SCREENING FOR OSTEOPOROSIS IN CROHNS-DISEASE - A DETAILED EVALUATION OF CALCANEAL ULTRASOUND, European journal of gastroenterology & hepatology, 10(2), 1998, pp. 137-140
Objectives To compare calcaneal broadband ultrasonic attenuation (BUA)
and velocity of sound (VOS) in patients with Crohn's disease with an
age-matched control population. The validity of BUA as a screening too
l for osteoporosis was evaluated and the relationship between BUA and
previous fracture studied. Design Cross-sectional study. Background Si
nce patients with Crohn's disease are at risk of osteoporosis and prem
ature fracture, routine assessment of bone mineral density (BMD) is re
commended. Quantitative ultrasound of the calcaneum is an inexpensive
and radiation-free means of assessing bone density which also provides
information on bone microstructure. Methods BUA (dB/MHz) and VOS (m/s
) were measured at the calcaneum (CUBAclinical, McCue Ultrasonics, Win
chester, UK) and compared with bone mineral density at the hip and lum
bar spine measured by dual-energy X-ray absorptiometry (DEXA); 100 pat
ients (42 men) with Crohn's disease and 52 age-matched healthy control
s (23 men) were studied. Results BUA was significantly reduced in pati
ents with Crohn's disease compared with age-matched controls [76.53 dB
/MHz (+/- 17.3) vs 87.29 dB/MHz (+/- 17.9), difference in means = 10.7
6, 95% CI -16.67, -4.85, P = 0.0004] and was significantly associated
with BMD at the spine (r = 0.49, 95% CI 0.32, 0.63, P < 0.0001) and fe
moral neck (r = 0.54, 95% CI 0.38, 0.67, P < 0.0001). In the diagnosis
of osteoporosis (t score < -2.5) BUA had a sensitivity of 66.7% at th
e femoral neck, with a specificity of 85.6%; sensitivity of BUA at the
spine was 75% with specificity 89%. Conclusion Patients with Crohn's
disease have reduced BUA compared with an age-matched control populati
on. Calcaneal BUA is significantly associated with BMD at the hip and
spine but the correlation is insufficient to recommend ultrasound as a
screening tool for DEXA. (C) 1998 Rapid Science Ltd.